The peroxisome proliferator-activated receptor alpha L162V mutation is associated with reduced adiposity. (Q53647540)

16 May 2018

title

The peroxisome proliferator-activated receptor alpha L162V mutation is associated with reduced adiposity. (English)

1 reference

16 May 2018

author

Louis Pérusse

series ordinal

4

1 reference

16 May 2018

Jean-Pierre Després

series ordinal

2

object named as

Jean-Pierre Després

1 reference

16 May 2018

3

Claude Bouchard

1 reference

16 May 2018

Yohan Bossé

1

1 reference

16 May 2018

Marie-Claude Vohl

series ordinal

5

1 reference

16 May 2018

publication date

1 July 2003

1 reference

16 May 2018

published in

Obesity

1 reference

16 May 2018

volume

11

1 reference

16 May 2018

issue

7

1 reference

16 May 2018

page(s)

809-816

1 reference

16 May 2018

Body mass index and future healthcare costs: a retrospective cohort study.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

The human obesity gene map: the 2000 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

A unified nomenclature system for the nuclear receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

The nuclear receptor superfamily: the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

THE VOLUME OF THE LUNG DETERMINED BY HELIUM DILUTION. DESCRIPTION OF THE METHOD AND COMPARISON WITH OTHER PROCEDURES

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

The gross composition of the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Influence of conjugated linoleic acid on body composition and target gene expression in peroxisome proliferator-activated receptor alpha-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Peroxisome proliterator-activated receptors, orphans with ligands and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Overweight and obesity in the United States: prevalence and trends, 1960-1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.112

31 March 2020

Identifiers

DOI

10.1038/OBY.2003.112

1 reference

16 May 2018

1 reference

16 May 2018